PRODUCTS

IGF-1 DES 1mg x 2ml vial
September 19, 2017
Rb1 1mg x 2ml
September 19, 2017

Letrozole 2.5mg/ml x 30ml vial

$35.99

Letrozole is a non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer.

Description

Letrozole is a non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Packaged as a research chemical, 2.5mg/ml x 30ml vial. AGRICON WILL DENY ANY ORDER IF WE FEEL IT WILL NOT BE USED TO THE CONDITIONS SPECIFIED IN OUR DISCLAIMER WHICH IS AGREED UPON BEFORE ENTERING THE STORE

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Letrozole 2.5mg/ml x 30ml vial”

Your email address will not be published. Required fields are marked *